Ranjan Jagath Rajapakse

This inventor holds 3 USPTO granted patents. Top assignees: Agouron Pharmaceuticals, Inc., Pfizer Corporation. Active years: 2002-2005.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ranjan Jagath Rajapakse. Retrieved from https://idiyas.com/inventor/ranjan-jagath-rajapakse

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3

Average Co-Inventor Count = 10.4

ph-index = 1

Forward Citations = 18(Granted Patents)

Location History:

Poway, CA (US) (2004)
San Diego, CA (US) (2002 - 2005)

Company Filing History:

2 out of 174

Agouron Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2002-2005

Loading Chart...

3 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6903132 - Non-peptide GnRH agents, pharmaceutical compositions and methods for their use (2005-06-07),

2. 6833372 - Non-peptide GnRH agents, Pharmaceutical compositions, and methods for their use (2004-12-21),

3. 6469021 - Non-peptide antagonists of GLP-1 receptor and methods of use (2002-10-22),

Title: Ranjan Jagath Rajapakse: Innovator in Pharmaceutical Sciences

Introduction

Ranjan Jagath Rajapakse is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of non-peptide GnRH agents. With a total of 3 patents, his work has implications for treating various reproductive disorders and hormone-dependent tumors.

Latest Patents

Rajapakse's latest patents include innovative pharmaceutical compositions and methods for using non-peptide GnRH agents. These agents are designed to inhibit the effects of gonadotropin-releasing hormone, making them suitable for treating mammalian reproductive disorders and steroid hormone-dependent tumors. His patents detail methods for synthesizing these compounds and their pharmaceutically acceptable salts, prodrugs, and active metabolites, which are essential for regulating fertility where suppression of gonadotropin release is indicated.

Career Highlights

Throughout his career, Rajapakse has worked with prominent companies in the pharmaceutical industry, including Agouron Pharmaceuticals, Inc. and Pfizer Corporation. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical treatments.

Collaborations

Rajapakse has collaborated with notable professionals in his field, including Yufeng Hong and Mark Brian Anderson. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his work.

Conclusion

Ranjan Jagath Rajapakse is a distinguished inventor whose work in pharmaceutical sciences has led to significant advancements in the treatment of reproductive disorders and hormone-dependent tumors. His innovative patents and collaborations reflect his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]